More pharmaceutical firms promoting M&A

Published: 2002-05-28 07:00:00

Updated: 2002-05-28 07:00:00

Pharmaceutical business sources say that the merger and acquisition (M&A) boom is fast spreading among domestic large pharmaceutical firms, including multinationals, in the wake of the inception of the previous IMF regime. The major factor prodding large pharmaceutical firms and foreign invested ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK